Feb 18 (Reuters) - Chemours Co CC.N:
CHEMOURS: OUTLOOK FY ADJUSTED EBITDA BETWEEN $825 MILLION AND $975 MILLION
CHEMOURS: OUTLOOK FY CAPITAL EXPENDITURES BETWEEN $250 MILLION TO $300 MILLION
CHEMOURS: OUTLOOK Q1 CONSOLIDATED NET SALES TO BE FLAT TO SLIGHTLY DOWN SEQUENTIALLY
CHEMOURS: QTRLY NET SALES OF $1.4 BILLION
CHEMOURS: QTRLY ADJUSTED EPS $0.11
CHEMOURS: IN 2024, FULLY REMEDIATED ALL FOUR MATERIAL WEAKNESSES IN INTERNAL CONTROL PREVIOUSLY IDENTIFIED IN THE 2023 FORM 10-K
Q4 EARNINGS PER SHARE VIEW $0.12, REVENUE VIEW $1.36 BILLION -- LSEG IBES DATA
Q1 REVENUE VIEW $1.41 BILLION -- LSEG IBES DATA
Source text: ID:nBwb2qq3ha
Further company coverage: CC.N